Clinical Trial Update: Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating clemastine to improve white matter integrity and antidepressant response in late-life depression; currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Clemastine (clemastine)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Depression | Phase 2 | Status: NOT_YET_RECRUITING